These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 15363007)

  • 21. Different bronchodilator combinations have similar effects on health status in COPD.
    Yildiz F; Basyigit I; Yildirim E; Boyaci H; Ilgazli A
    Pulm Pharmacol Ther; 2006; 19(2):101-6. PubMed ID: 15967694
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Addition of inhaled corticosteroid on combined bronchodilator therapy in patients with COPD.
    Basyigit I; Yildiz F; Ozkara SK; Yildirim E; Boyaci H; Ilgazli A
    Pulm Pharmacol Ther; 2005; 18(6):422-6. PubMed ID: 15955716
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of levalbuterol and racemic albuterol in hospitalized patients with acute asthma or COPD: a 2-week, multicenter, randomized, open-label study.
    Donohue JF; Hanania NA; Ciubotaru RL; Noe L; Pasta DJ; Schaefer K; Claus R; Andrews WT; Roach J
    Clin Ther; 2008; 30 Spec No():989-1002. PubMed ID: 18640474
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Withdrawal of fluticasone propionate from combined salmeterol/fluticasone treatment in patients with COPD causes immediate and sustained disease deterioration: a randomised controlled trial.
    Wouters EF; Postma DS; Fokkens B; Hop WC; Prins J; Kuipers AF; Pasma HR; Hensing CA; Creutzberg EC;
    Thorax; 2005 Jun; 60(6):480-7. PubMed ID: 15923248
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bronchodilator reversibility, airway eosinophilia and anti-inflammatory effects of inhaled fluticasone in COPD are not related.
    Reid DW; Wen Y; Johns DP; Williams TJ; Ward C; Walters EH
    Respirology; 2008 Nov; 13(6):799-809. PubMed ID: 18811878
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term effects of budesonide on inflammatory status in COPD.
    Boorsma M; Lutter R; van de Pol MA; Out TA; Jansen HM; Jonkers RE
    COPD; 2008 Apr; 5(2):97-104. PubMed ID: 18415808
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhaled corticosteroids as additional treatment in alpha-1-antitrypsin-deficiency-related COPD.
    Corda L; Bertella E; La Piana GE; Boni E; Redolfi S; Tantucci C
    Respiration; 2008; 76(1):61-8. PubMed ID: 18319586
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Application of St George's respiratory questionnaire in evaluating the life quality of Chinese patients with chronic obstructive pulmonary disease].
    Lu WX; Zhang YJ; Hu B; Ma Y; Zhu YJ
    Zhonghua Jie He He Hu Xi Za Zhi; 2003 Apr; 26(4):195-8. PubMed ID: 12901823
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plant-based formulation in the management of chronic obstructive pulmonary disease: a randomized double-blind study.
    Murali PM; Rajasekaran S; Paramesh P; Krishnarajasekar OR; Vasudevan S; Nalini K; Lakshmisubramanian S; Deivanayagam CN
    Respir Med; 2006 Jan; 100(1):39-45. PubMed ID: 15905081
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Inhaled corticosteroids in patients with COPD: maintain current guidelines].
    Heijdra YF
    Ned Tijdschr Geneeskd; 2007 Oct; 151(40):2195-7. PubMed ID: 17969568
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Positive benefits of theophylline in a randomized, double-blind, parallel-group, placebo-controlled study of low-dose, slow-release theophylline in the treatment of COPD for 1 year.
    Zhou Y; Wang X; Zeng X; Qiu R; Xie J; Liu S; Zheng J; Zhong N; Ran P
    Respirology; 2006 Sep; 11(5):603-10. PubMed ID: 16916334
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhaled corticosteroids in chronic obstructive pulmonary disease: a review.
    Telenga ED; Kerstjens HA; Postma DS; Ten Hacken NH; van den Berge M
    Expert Opin Pharmacother; 2010 Feb; 11(3):405-21. PubMed ID: 20102305
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of acute bronchodilator reversibility in patients with symptoms of GOLD stage I COPD.
    O'Donnell DE; Laveneziana P; Ora J; Webb KA; Lam YM; Ofir D
    Thorax; 2009 Mar; 64(3):216-23. PubMed ID: 19052054
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Evaluation and symptomatic treatment of surinfectious exacerbations of COPD: preliminary study of antibiotic treatment combined with fenspiride (Pneumorel 80mg) versus placebo].
    Lirsac B; Benezet O; Dansin E; Nouvet G; Stach B; Voisin C
    Rev Pneumol Clin; 2000 Feb; 56(1):17-24. PubMed ID: 10740110
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of inhaled therapies on health-related quality of life in stable chronic obstructive pulmonary disease.
    Antoniu SA
    Expert Rev Pharmacoecon Outcomes Res; 2010 Apr; 10(2):155-62. PubMed ID: 20384562
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identifying COPD patients at increased risk of mortality: predictive value of clinical study baseline data.
    Halpin DM; Peterson S; Larsson TP; Calverley PM
    Respir Med; 2008 Nov; 102(11):1615-24. PubMed ID: 18691861
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stable COPD: predicting benefit from high-dose inhaled corticosteroid treatment.
    Leigh R; Pizzichini MM; Morris MM; Maltais F; Hargreave FE; Pizzichini E
    Eur Respir J; 2006 May; 27(5):964-71. PubMed ID: 16446316
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinical study of inhaled corticosteroid in non-asthmatic chronic obstructive pulmonary disease].
    Ouyang R; Yin B
    Zhonghua Jie He He Hu Xi Za Zhi; 1998 Aug; 21(8):497-9. PubMed ID: 11360524
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effects of salbutamol and ipratropium bromide on arterial blood gases in patients with stable COPD].
    Ozdemir T; Geçkin E; Oğüş C; Cilli A
    Tuberk Toraks; 2003; 51(2):132-7. PubMed ID: 15143418
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A randomized, controlled multicentric study of inhaled budesonide and intravenous methylprednisolone in the treatment on acute exacerbation of chronic obstructive pulmonary disease.
    Ding Z; Li X; Lu Y; Rong G; Yang R; Zhang R; Wang G; Wei X; Ye Y; Qian Z; Liu H; Zhu D; Zhou R; Zhu K; Ni R; Xia K; Luo N; Pei C
    Respir Med; 2016 Dec; 121():39-47. PubMed ID: 27888990
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.